remdesivir
Latest
Antiviral remdesivir appears safe for children
The antiviral drug remdesivir appears to be as safe and effective for use in children with COVID-19 as in adults, according to the largest study to date of children with…
Remdesivir cut COVID-19 recovery time by 5 days
Final data from a large study of Gilead Sciences Inc's antiviral drug remdesivir showed the treatment cut COVID-19 recovery time by five…
EU signs joint procurement contract for remdesivir supply
The European Commission said on Thursday it had signed a contract with U.S. drugmaker Gilead for the supply of up to 500,000…
EU has agreed supply of 20,000 additional doses of Remdesivir
The European Commission said on Wednesday it had agreed with U.S. company Gilead the supply of more than 20,000 additional doses of…
European countries facing shortage of Covid-19 drug remdesivir
European countries are facing shortages of COVID-19 drug remdesivir because limited supplies are running out, officials said, with cases surging and the…
World takes stock of COVID-19 drug remdesivir after U.S. snaps up supplies
Some governments in Europe and Asia said they have enough of Gilead’s COVID-19 anti-viral remdesivir for now despite fears of shortages since…
EU drugs agency evaluates potential coronavirus treatment
The European Medicines Agency said Thursday it will start a rolling review of remdesivir, an investigational therapy for COVID-19 originally developed by…
Gilead disputes report that its drug flopped in leaked coronavirus trial
A closely-watched Gilead Sciences Inc experimental antiviral drug failed to help patients with severe COVID-19 in a clinical trial conducted in China,…
Potential antiviral drug for coronavirus fails in its first clinical trial
A potential antiviral drug for the coronavirus has reportedly failed in its first randomised clinical trial. There had been widespread hope that…